Display options
Cite
Archer R. The drug discovery factory: An inevitable evolutionary consequence of high-throughput parallel processing. Nat Biotechnol. 1999;17(9):834doi: 10.1038/12782.
Archer, R. (1999). The drug discovery factory: An inevitable evolutionary consequence of high-throughput parallel processing. Nature biotechnology, 17(9), 834. https://doi.org/10.1038/12782
Archer, R. "The drug discovery factory: An inevitable evolutionary consequence of high-throughput parallel processing." Nature biotechnology vol. 17,9 (1999): 834. doi: https://doi.org/10.1038/12782
Archer R. The drug discovery factory: An inevitable evolutionary consequence of high-throughput parallel processing. Nat Biotechnol. 1999 Sep;17(9):834. doi: 10.1038/12782. PMID: 10471905.
Copy Download .nbib Format: NLM
Share it on

Nat Biotechnol. 1999 Sep;17(9):834. doi: 10.1038/12782.

The drug discovery factory: An inevitable evolutionary consequence of high-throughput parallel processing.

Nature biotechnology

R Archer

Affiliations

  1. Richard Archer is chief executive of The Automation Partnership, Melbourn Science Park, Melbourn, Royston SG8 6HB, UK. [email protected]

PMID: 10471905 DOI: 10.1038/12782

[No abstract available.]

MeSH terms

Publication Types